SPLUNK INC
Technology · Services-Prepackaged Software · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | |
|---|---|---|---|---|---|---|
| Revenue | $3.65B | $2.67B | $2.23B | $2.36B | $1.80B | $1.31B |
| Operating income | −$235.5M | −$1.15B | −$780.2M | −$287.1M | −$251.2M | −$185.4M |
| Net income | — | — | — | — | — | — |
| Total assets | $6.34B | $5.79B | $5.87B | $5.44B | $4.50B | $2.14B |
| Total liabilities | $6.45B | $5.57B | $4.27B | $3.44B | $2.98B | $1.01B |
| Equity | −$110.5M | $222.8M | $1.59B | $2.00B | $1.52B | $1.13B |
| EPS (diluted) | $-1.71 | $-8.29 | $-5.68 | $-2.22 | — | — |
| Shares out. | 165.5M | 160.7M | 163.8M | 158.6M | 150.1M | 144.0M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2023- Operating margin
- −6.4%
- Net margin
- —
- Return on equity
- —
- Return on assets
- —
- Return on capital (ROCE)
- −7.1%
- Liabilities / assets
- 101.7%
- Debt / equity
- —
- Book value / share
- $-0.67
- Revenue growth (YoY)
- 36.7%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2023- Altman Z″ (distress)
- -1.35distress
- Piotroski F-Score
- 3/6weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 2 warning● 2 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Operating losses (negative operating margin)
- High leverage (liabilities > 70% of assets)
- Revenue is growing year-over-year
- Positive operating cash flow
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsMar 18, 2024
- Results of operations · Regulation FD disclosureFeb 27, 2024
- Director / officer changeDec 21, 2023
- Shareholder voteNov 30, 2023
- Results of operations · Regulation FD disclosureNov 28, 2023
- Other material eventNov 17, 2023
- Other material eventNov 14, 2023
- Costs from exit or disposal · Regulation FD disclosureNov 1, 2023
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.